August 05, 2013
4 min read
Save

Children prescribed antibiotics for UTIs not always tested

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Many children treated with antibiotics for a urinary tract infection are never tested, according to recent study findings published in Pediatrics.

Perspective from Ellen Wald, MD

“We found not only that urine cultures were performed in <60% of antibiotic-treated UTI episodes, but also that in [about] 20% of antibiotic-treated UTI episodes no urine testing (urinalysis or urine culture) was done,” Hillary L. Copp, MD, MS, of the University of California, and colleagues wrote.

 

Hillary L. Copp

The study included 28,678 children aged younger than 18 years who had an outpatient UTI and a temporally associated antibiotic prescription from 2002 to 2007.

The researchers found 40,603 antibiotic-treated UTI episodes among the participants during the study period. Among the total UTI episodes, urinalysis was performed in 76% and urine culture was performed in 57%.

Variations were also found among urine culture use for those aged younger than 2 years (OR=1.0; 95% CI, 0.9-1.1),  2 to 5 years (OR=1.3; 95% CI, 1.2-1.4),  and 6 to 12 years (OR=1.3; 95% CI, 1.2-1.4) vs. those aged 13 to 17 years. Sex (boys, OR=0.8; 95% CI, 0.8-0.9) and specialty (pediatrics, OR=2.6; 95% CI, 2.5-2.8; emergency medicine, OR=1.2; 95% CI, 1.1-1.3; urology, OR=0.5; 95% CI, 0.4-0.6; vs. family/internal medicine) also varied when it came to urine culture use.

“Empiric treatment for UTI without urine testing may be appropriate in certain pediatric populations that have symptoms of a standard, non-febrile UTI,” Copp told Infectious Diseases in Children. “However, urine testing remains an essential aspect of UTI management not only for the ability to appropriately tailor empiric therapy for children with resistant UTI, but also to clarify the underlying diagnosis and prevent over-treatment in pediatric patients.”

 

Hillary L. Copp, MD, MS, can be reached at 400 Parnassus Ave, A610, San Francisco, CA, 94143; email: copphl@urology.ucsf.edu.

Disclosure: The study was funded in part by NIH. Copp is support by the University of California, San Francisco KURe Career Development Program.